VRTX VERTEX PHARMACEUTICALS INC / MA

NEUTRAL Impact: 3/10 Insider Cluster (2 insiders)
Horizon immediate Filed Mar 11, 2026 Processed 2mo ago
Insider cluster: 2 insiders, $2.4M total
Latest settled — T+20d
VRTX ▼ -9.21% at T+20d
NEUTRAL call ✗ call lost -9.21% · α vs SPY -9.74% · entry $491.96 → $446.63
Next anchor: T+60d in 15d
Currently $430.44 · -12.50% from $491.96 entry
Entry anchored
Mar 10, 03:59 PM ET
via Databento tick
T+1d
-2.84%
call -2.84% · α -1.36%
$477.98
settled 2mo ago
T+5d
-8.20%
call -8.20% · α -6.01%
$451.61
settled 2mo ago
T+20d
-9.21%
call -9.21% · α -9.74%
$446.63
settled 6w ago
T+60d
call — · α —
in 15d

Price Chart

Loading chart...

Executive Summary

Two Vertex Pharmaceuticals EVPs — the Chief Medical Officer and Chief Commercial Officer — sold shares in open-market transactions totaling approximately $2.45 million. The sales were modest in dollar value relative to the company's $118.4 billion market cap, representing just 0.002% of market value.

Key Financial Metrics

Direction
selling
Total Value
$2.4M
Insiders
2

Actionable Insight

These sales are routine from a dollar and volume perspective and not indicative of negative sentiment given their small scale relative to company size. Traders should monitor for additional selling or commentary around earnings or pipeline updates.

Key Facts

  • EVP and CMO Carmen Bozic sold 2,329 shares for $1,122,088.91 on March 13, 2026, at $481.79 per share.
  • EVP and Chief Commercial Officer Duncan McKechnie sold 2,633 shares for $1,312,339.86 on March 11, 2026, at $498.42 per share.
  • Total insider sales in cluster: $2,434,428.77 across two C-suite executives.
  • Sales represent approximately 0.002% of Vertex's $118.4B market cap — well below the 0.1% threshold for materiality.

Financial Impact

$2.43 million in total open-market sales by two executives

insider ownershipmarket sentiment

Risk Factors

  • Perception risk if more executives sell in coming days.
  • Potential misinterpretation as bearish signal despite lack of materiality.

Market Snapshot

Exchange
Nasdaq
Analyst Consensus
79% bullish (39 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (2 trades, 7d window)cluster-VRTX-1773777879078
8 reports for VRTX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for VRTX — sortable, filterable
Type Now
May 19, 2026
1d ago
Insider Cluster
NEUTRAL ★ 2/10
awaiting T+20
May 1, 2026
19d ago
ANALYST-UPGRADE
MIXED ★ 1/10
$451.61 $433.64▼ −3.98%▼ −10.03%$430.44 (−4.69%)
Mar 11, 2026
10w ago
Insider Cluster
NEUTRAL ★ 3/10
$491.96 $446.63▼ −9.21%▼ −9.74%$430.44 (−12.50%)
Feb 25, 2026
12w ago
Insider Cluster
NEUTRAL ★ 4/10
$482.92 $454.96▼ −5.79%▼ −0.55%$430.44 (−10.87%)
Feb 25, 2026
12w ago
Insider Cluster
BEARISH ★ 6/10
$482.92 $454.96▲ +5.79%▲ +0.55%$430.44 (+10.87%)
Feb 25, 2026
12w ago
Insider Cluster
NEUTRAL ★ 3/10
$482.92 $454.96▼ −5.79%▼ −0.55%$430.44 (−10.87%)
Feb 25, 2026
12w ago
Insider Cluster
NEUTRAL ★ 4/10
$482.92 $454.96▼ −5.79%▼ −0.55%$430.44 (−10.87%)
Feb 25, 2026
12w ago
Insider Cluster
NEUTRAL ★ 3/10
$482.92 $454.96▼ −5.79%▼ −0.55%$430.44 (−10.87%)
Showing 8 of 8

US Market Status

Market Closed — Opens Thu (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access